- Home
- IMSR vs PACB Comparison
IMSR vs PACB Comparison
Compare IMSR & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMSR | PACB |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | United States | United States |
| Employees | 74 | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 571.5M | 521.8M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | IMSR | PACB |
|---|---|---|
| Price | $4.94 | $1.36 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $1.67 |
| AVG Volume (30 Days) | 2.0M | ★ 5.9M |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | N/A | $11.32 |
| Revenue Next Year | N/A | $12.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $4.38 | $1.09 |
| 52 Week High | $16.38 | $2.73 |
Technical Indicators
Market Signals| Indicator | IMSR | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 32.05 | 40.48 |
| Support Level | N/A | $1.29 |
| Resistance Level | $7.07 | $1.79 |
| Average True Range (ATR) | 0.45 | 0.11 |
| MACD | -0.15 | -0.03 |
| Stochastic Oscillator | 18.87 | 3.03 |
Price Performance
Historical ComparisonAbout IMSR Terrestrial Energy Inc.
Terrestrial Energy Inc is a technology company engaged in the development and commercialization of nuclear power plants. The company is focused on its proprietary Integral Molten Salt Reactor (IMSR) technology, a Generation IV reactor design intended to produce reliable, emission-free energy in the form of electricity and high-temperature heat for industrial applications. Its activities mainly involve advancing the design, licensing, and deployment of IMSR plants for commercial energy generation.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.